Global Mycoplasma Detection and Decontamination Services Market Growth (Status and Outlook) 2025-2031

The global Mycoplasma Detection and Decontamination Services market size is predicted to grow from US$ 227 million in 2025 to US$ 294 million in 2031; it is expected to grow at a CAGR of 4.4% from 2025 to 2031.

Mycoplasma detection and decontamination services detect and eliminate mycoplasma contamination in cell cultures. Mycoplasma contamination is a common problem that can affect the results of cell-based experiments. Detection is typically performed by PCR, ELISA, or other molecular methods, while decontamination involves eliminating contaminants and preventing further problems.

United States market for Mycoplasma Detection and Decontamination Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Mycoplasma Detection and Decontamination Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Mycoplasma Detection and Decontamination Services is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Mycoplasma Detection and Decontamination Services players cover Applied Biological Materials Inc. (abm), Thermo Fisher Scientific, Creative Bioarray, BaseClear, QED Bioscience Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Mycoplasma Detection and Decontamination Services Industry Forecast” looks at past sales and reviews total world Mycoplasma Detection and Decontamination Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Mycoplasma Detection and Decontamination Services sales for 2025 through 2031. With Mycoplasma Detection and Decontamination Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mycoplasma Detection and Decontamination Services industry.

This Insight Report provides a comprehensive analysis of the global Mycoplasma Detection and Decontamination Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Mycoplasma Detection and Decontamination Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mycoplasma Detection and Decontamination Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mycoplasma Detection and Decontamination Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mycoplasma Detection and Decontamination Services.

This report presents a comprehensive overview, market shares, and growth opportunities of Mycoplasma Detection and Decontamination Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
PCR-based Mycoplasma Detection
Enzyme Detection
Fluorescent Staining
Other

Segmentation by Application:
Biomedicine
Cell Therapy and Genetic Engineering
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Applied Biological Materials Inc. (abm)
Thermo Fisher Scientific
Creative Bioarray
BaseClear
QED Bioscience Inc
QTCC
Charles River Laboratories
Minerva Biolabs
InvivoGen
R&D Systems

Please note: The report will take approximately 2 business days to prepare and deliver.